Carcinoma in situ i mammae

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Carcinoma in situ i mammae. / Skaar, Marica; Langhans, Linnea; Mertz, Birgitte; Kroman, Niels.

I: Ugeskrift for Laeger, Bind 180, Nr. 38, V01170084, 2018.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Skaar, M, Langhans, L, Mertz, B & Kroman, N 2018, 'Carcinoma in situ i mammae', Ugeskrift for Laeger, bind 180, nr. 38, V01170084. <http://ugeskriftet.dk/videnskab/carcinoma-situ-i-mammae>

APA

Skaar, M., Langhans, L., Mertz, B., & Kroman, N. (2018). Carcinoma in situ i mammae. Ugeskrift for Laeger, 180(38), [V01170084]. http://ugeskriftet.dk/videnskab/carcinoma-situ-i-mammae

Vancouver

Skaar M, Langhans L, Mertz B, Kroman N. Carcinoma in situ i mammae. Ugeskrift for Laeger. 2018;180(38). V01170084.

Author

Skaar, Marica ; Langhans, Linnea ; Mertz, Birgitte ; Kroman, Niels. / Carcinoma in situ i mammae. I: Ugeskrift for Laeger. 2018 ; Bind 180, Nr. 38.

Bibtex

@article{8294106152d74af0a22612a47bb108e9,
title = "Carcinoma in situ i mammae",
abstract = "Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.",
author = "Marica Skaar and Linnea Langhans and Birgitte Mertz and Niels Kroman",
year = "2018",
language = "Dansk",
volume = "180",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "38",

}

RIS

TY - JOUR

T1 - Carcinoma in situ i mammae

AU - Skaar, Marica

AU - Langhans, Linnea

AU - Mertz, Birgitte

AU - Kroman, Niels

PY - 2018

Y1 - 2018

N2 - Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.

AB - Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.

M3 - Tidsskriftartikel

C2 - 30259839

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 38

M1 - V01170084

ER -

ID: 221830307